![Alessandra Cervino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alessandra Cervino
Keine laufenden Positionen mehr
Karriereverlauf von Alessandra Cervino
Ehemalige bekannte Positionen von Alessandra Cervino
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Glasgow | Corporate Officer/Principal | - | - |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Corporate Officer/Principal | - | - |
Oxford GlycoSciences Plc
![]() Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Corporate Officer/Principal | - | - |
King's College London | Corporate Officer/Principal | - | - |
MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Scripps Florida Funding Corp. | Corporate Officer/Principal | - | - |
Tc Land Expression SA
![]() Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2008 | - |
Ausbildung von Alessandra Cervino
University of Oxford | Doctorate Degree |
The University of Reading | Graduate Degree |
Université Libre de Bruxelles | Graduate Degree |
Statistik
International
Vereinigtes Königreich | 6 |
Frankreich | 3 |
Vereinigte Staaten | 3 |
Operativ
Corporate Officer/Principal | 6 |
Graduate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Consumer Services | 6 |
Health Technology | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Tc Land Expression SA
![]() Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Commercial Services |
Scripps Florida Funding Corp. | |
Oxford GlycoSciences Plc
![]() Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
- Börse
- Insiders
- Alessandra Cervino
- Erfahrung